Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.3K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

402
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
402
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

378
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
378
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

387
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
387
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

2.0K
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
2.0K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Early Symptomatic Alzheimer Disease With Valacyclovir-Reply.

JAMA·2026
Same author

Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial.

JAMA·2025
Same author

Neuropathological Correlates of Apathy Progression in Alzheimer's Disease and Related Dementias: A Longitudinal NACC Cohort Study.

bioRxiv : the preprint server for biology·2025
Same author

Feasibility and tolerability of low-dose lithium for the treatment of agitation and abnormal motor behaviors in Frontotemporal Dementia.

International review of psychiatry (Abingdon, England)·2025
Same author

COVID-19 olfactory dysfunction: associations between coping, quality of life, and mental health.

Rhinology·2024
Same author

Recovery rates of persistent post-COVID-19 olfactory dysfunction using psychophysical assessment: A longitudinal cohort study.

World journal of otorhinolaryngology - head and neck surgery·2024

Related Experiment Video

Updated: May 6, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.6K

Dysthymic disorder in the elderly population.

D P Devanand1

  • 1Division of Geriatric Psychiatry, College of Physicians and Surgeons, Columbia University, New York, USA.

International Psychogeriatrics
|October 25, 2013
PubMed
Summary
This summary is machine-generated.

Dysthymic disorder, now persistent depressive disorder, affects 2% of older adults. In this group, it often presents later in life and is linked to increased disability and poor health outcomes, requiring better primary care identification and treatment.

More Related Videos

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

3.0K
Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

1.4K

Related Experiment Videos

Last Updated: May 6, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.6K
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

3.0K
Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

1.4K

Area of Science:

  • Geriatric Psychiatry
  • Mental Health Research
  • Clinical Psychology

Background:

  • Dysthymic disorder, a diagnosis from DSM-III/IV, describes chronic, mild-to-moderate depression.
  • It was replaced by persistent depressive disorder in DSM-V, encompassing chronic major depression and dysthymic disorder.
  • In older adults, dysthymic disorder (DD) is prevalent (approx. 2%) and often presents with late onset, distinct from younger adults.

Purpose of the Study:

  • To review the characteristics, impact, and treatment of dysthymic disorder in the elderly population.
  • To highlight the unique presentation of DD in older adults compared to younger populations.
  • To assess the current state of identification and treatment of DD in primary care settings for elderly patients.

Main Methods:

  • Literature review and synthesis of epidemiological and clinical evidence.
  • Analysis of diagnostic criteria changes across DSM editions (DSM-III, DSM-IV, DSM-V).
  • Examination of treatment efficacy data for antidepressant medications and psychotherapy in older adults.

Main Results:

  • Older adults with DD often have late-onset, lack comorbid psychiatric disorders, and have fewer family mood disorder histories.
  • Common stressors include social loss and bereavement; some exhibit cerebrovascular or neurodegenerative pathology.
  • Both DD and subsyndromal depression in the elderly significantly increase disability and negatively impact medical outcomes.

Conclusions:

  • Dysthymic disorder in older adults presents uniquely and contributes to significant functional impairment and poor health.
  • Current identification and treatment in primary care are often inadequate, despite available therapeutic options.
  • Further research is essential to establish optimal, cost-effective treatment strategies for elderly patients with dysthymic disorder.